Brookfield and CDPQ Complete Acquisition of Antylia Scientific
Brookfield Asset Management (NYSE, TSX: BAM) through one of its private equity funds, together with its listed affiliate Brookfield Business Partners (NYSE: BBU, BBUC; TSX: BBU.UN, BBUC) and global investment group CDPQ, today announced that they have completed the acquisition of Antylia Scientific (“Antylia”) for approximately $1.3 billion.
Antylia is a leading manufacturer and distributor of consumables and testing equipment serving diagnostics, environmental and life sciences labs. The business manufactures and sells essential products that support the accuracy and repeatability of processes in labs and benefits from a diverse and long-term customer base which supports its strong cash flow generation.
Anuj Ranjan, CEO, Brookfield’s Private Equity Group, said: “We’re excited to complete the acquisition of Antylia alongside our partners at CDPQ. We look forward to drawing on our deep operating expertise in industrials and manufacturing to enhance the business in areas such as commercial strategy and procurement, supporting its next phase of growth.”
Martin Longchamps, Executive Vice-President and Head of Private Equity and Private Credit at CDPQ, said: “We are investing with our long-standing partner Brookfield in Antylia, a business supplying critical products to professionals in the life and environmental sciences sectors. Together, we see an opportunity to support its continued growth and reinforce its position as a market leader.”
Antylia marks Brookfield’s latest transaction in the U.S. industrial and manufacturing sector, following the acquisition of Chemelex, a global leader in electric heat trace systems, earlier this year. Brookfield brings extensive global expertise of investing and driving operational transformation in industrial and manufacturing businesses. Other investments have included Clarios, the global leader in advanced low-voltage batteries and Westinghouse, a leader in providing mission-critical technologies, products and services to the nuclear power industry.
ABOUT BROOKFIELD ASSET MANAGEMENT
Brookfield Asset Management (NYSE: BAM, TSX: BAM) is a leading global alternative asset manager, headquartered in New York, with over $1 trillion of assets under management across renewable power and transition, infrastructure, private equity, real estate and credit. We invest client capital for the long-term with a focus on real assets and essential service businesses that form the backbone of the global economy. We offer a range of alternative investment products to investors around the world — including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies and private wealth investors. We draw on Brookfield’s heritage as an owner and operator to invest for value and generate strong returns for our clients, across economic cycles.
Brookfield’s private equity business, which manages over $145 billion of assets under management, focuses on driving operational transformation in businesses providing essential products and services.
ABOUT CDPQ
At CDPQ, we invest constructively to generate sustainable returns over the long term. As a global investment group managing funds for public pension and insurance plans, we work alongside our partners to build enterprises that drive performance and progress. We are active in the major financial markets, private equity, infrastructure, real estate and private debt. As at December 31, 2024, CDPQ’s net assets totalled CAD 473 billion. For more information, visit cdpq.com, consult our LinkedIn or Instagram pages, or follow us on X.
CDPQ is a registered trademark owned by Caisse de dépôt et placement du Québec and licensed for use by its subsidiaries.
- 30 -
For more information